Although the adherence level of Iranian HIV infected patients is acceptable compared to other countries, the available antiretroviral medications are limited in our country, therefore, encouraging patients to have higher levels of adherence is more important.

In Malaysia, there is an increase in both demand and prescribing of supplements. Such trend raises the likelihood of adverse events and treatment costs. Numerous prescribing policies have been suggested for better utilization of resources. However, the adherence and improvement from such policies are yet to be fully characterized.